Sustained viral response and relapse after discontinuation of oral antiviral drugs in HBeAg-positive patients with chronic hepatitis B infection.
Sun F, Li Z, Hu L, Deng W, Jiang T, Wang S, Bi X, Lu H, Yang L, Lin Y, Zeng Z, Shen G, Liu R, Chang M, Wu S, Gao Y, Hao H, Xu M, Chen X, Zhang L, Lu Y, Dong J, Xie Y, Li M.
Sun F, et al. Among authors: yang l.
Front Immunol. 2022 Nov 25;13:1082091. doi: 10.3389/fimmu.2022.1082091. eCollection 2022.
Front Immunol. 2022.
PMID: 36505492
Free PMC article.